After a booming few years of growth in digital health, things returned to a normal cadence in 2022. Yet not all was quiet either: the femtech market continued to grow and Europe launched its first-ever digital health action plan. In this blog, we recap the most notable developments in 2022.
The digital therapeutic (DTx) landscape is rapidly evolving with DTx securing a record-breaking $3.4B across 122 investments in 2021
The COVID-19 pandemic has devastated the world and has left significant lasting consequences on many sectors, particularly the clinical research and clinical trials industry. Clinical trials are an essential component of the drug approval process and provide vital information about a drug's safety.